Entero Healthcare Solutions credit ratios

·Consumer ServicesChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024
567567299276
275275−19.2−618
0.32×0.32×0.17×0.17×
0.16×0.16×−0.01×−0.38×
2.13×2.13×1.74×2.46×
0.88×1.03×−0.11×−5.52×
4.09×4.09×3.38×1.32×
24.4%24.4%14.4%14.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ENTERO₹1,470.00

Entero Healthcare Solutions Ltd.

· Consumer Services
₹ CrorePeersMEDPLUSEMILCRIZACGPPLCMSINFOHEMIPROPBLACKBUCKINOXGREENMcap ₹6,396 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt—275.6298.8566.7566.7
Net Debt—-617.6-19.2275.0275.0
Total Debt/Equity—0.170.170.320.32
Net Debt/Equity—-0.38-0.010.160.16
Total Debt/EBITDA—2.461.742.132.13
Net Debt/EBITDA—-5.52-0.111.030.88
Interest Coverage (EBIT/Interest)—1.323.384.094.09
Total Debt/Total Capital %—14.3714.4424.4324.43
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.